Amphotericin B is an antifungal medicine used for serious fungal infections and for leishmaniasis. The infections it treats include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis and cryptococcosis, and it is sometimes a last resort drug for primary amoebic meningoencephalitis. It is typically given intravenously and belongs to the polyene class, working in part by interfering with the fungal cell membrane. Fever, chills and headache soon after a dose are common, as are kidney problems, and a lipid formulation carries a lower risk of side effects. It was isolated in 1955 at the Squibb Institute for Medical Research from a streptomycete found on the Orinoco river bed in Venezuela, entered medical use in 1958 and appears on the World Health Organization List of Essential Medicines.
Facts
Classification
Approval Status ATC ClassJ: Antiinfectives for Systemic Use 1 Route of Administration WHO Essential Medicine First Approved / Isolated Year Connections
Treats
Source Amphotericin B (Wikipedia)
Sources
1. Amphotericin B (Wikipedia)
Lead section
is an antifungal medication used for serious fungal infections and leishmaniasis
Lead section [route-of-administration]
It is typically given intravenously.
Lead section [approval-status]
came into medical use in 1958
Treats: Leishmaniasis, Lead section [treats]
used for serious fungal infections and leishmaniasis
View the Source2. World Health Organization: The selection and use of essential medicines, 2025: WHO Model List of Essential Medicines, 24th list
World Health OrganizationPDF page 24; section 6.3; the entry amphotericin B is in the Core List of the WHO Model List of Essential Medicines, 24th list (2025)Quote, PDF page 24; section 6.3; the entry amphotericin B is in the Core List of the WHO Model List of Essential Medicines, 24th list (2025)
amphotericin B* clotrimazole
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.